Open

Food Allergy Study

The purpose of this study is to determine if the use of a drug called RPT904 is safe and effective for reducing allergic reactions that may occur upon accidental exposure to food allergens.

I'm interested

Age & Gender

12 years ~ 55 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

North Carolina (Statewide)

What will be asked of you

The following procedures/assessments are a part of the study: -Medical history, diet, allergy questionnaires -Physical exams -Vital signs (blood pressure, temperature, heart rate) -Teaching on epinephrine auto-injectors -Lung function testing -Administration of the study drug -Pregnancy testing (blood and urine) if able to become pregnant -Laboratory testing (blood and urine) -Skin prick testing -Oral food challenges

Incentives

Information provided upon request

In-person visits:
22

Total length of participation:
17 months

Looking for Specific Volunteers

Able to participate:

Allergic to at least 1 of the following foods: peanut, milk, egg, cashew, or walnut
Ages 12 years to less than 56 years

Not eligible if:

Previous adverse reaction to omalizumab/omalizumab-igec or discontinuation of omalizumab/omalizumab-igec treatment due to insufficient clinical benefit.
Current participation in another therapeutic or interventional clinical study or participation within 90 days of screening or use of investigational drugs within 24 weeks ofscreening
Currently on "build-up phase" of inhalant allergen immunotherapy (ie, has not reached maintenance dosing).
Currently receiving oral, IM, or IV corticosteroids, tricyclic antidepressants, or β-blockers (oral or topical).
Past or current history of any immunotherapy to any of the foods being treated in this study (eg, oral immunotherapy, sublingual immunotherapy, epicutaneous immunotherapy) within

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

UNC Food Allergy Initiative
foodallergy@unc.edu

Primary Visit Location

Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Edwin Kim
Pediatrics - Allergy Immunology and Rheumatology

Study Type

Clinical or Medical
Interventional

Study Topics

Allergy
Immune System/Infections

IRB Number

25-2552

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.